FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2084629567> ?p ?o ?g. }

• W2084629567 endingPage "1596" @default.
• W2084629567 startingPage "1589" @default.
• W2084629567 abstract "The immunosuppressive and anti-inflammatory drug leflunomide has several sites of action, although its precise mode of action is unknown. Here we show in vitro and in vivo that leflunomide and/or its active metabolite A771726, inhibit the activity of cyclo-oxygenase (COX) at doses below those that affect protein expression. In J774.2 macrophages treated with endotoxin for 24 h to induce COX-2 and iNOS, leflunomide and A771726 inhibited more potently the accumulation of PGE2 (A771726, IC50 3.5 μg ml−1) than of NO2 (A771726, IC50 380 μg ml−1). At high concentrations (>300 μg ml−1) A771726 also exhibited the expression of COX-2 and iNOS proteins. In A549 cells treated for 24 h with interleukin-1β, to induce COX-2, A771726 potently inhibited PGE2 synthesis (IC50 0.13 μg ml−1). In the same cells, A771726 was notably less active (IC50, 52 μg ml−1) at inhibiting the formation of PGE2 stimulated by exposure to 30 μM arachidonic acid. In a human whole blood assay, measuring the accumulation of TxB2 in response to calcium ionophore as a measure of COX-1 activity and in response to incubation with bacterial endotoxin as a measure of COX-2 activity, leflunomide inhibited COX-1 and COX-2 with IC50 values of 31 and 185 μg ml−1; for A771726 the corresponding values were 40 and 69 μg ml−1. Pre-treatment of rats with leflunomide or A771726 (10 mg kg−1, i.p.) inhibited the plasma accumulation of 6-keto-PGF1α but not NO2/NO3 following infusion of endotoxin. Injection of a bolus of arachidonic acid following 6 h infusion of endotoxin caused a marked acute rise in plasma 6-keto-PGF1α which was inhibited only by higher doses of A771726 (50 mg kg−1, i.p.). In conclusion, leflunomide via A771726 can directly inhibit the activity of COX, an effect that appears blunted both by increases in substrate supply and possibly by plasma binding. Only at much higher drug levels does leflunomide and/or A771726 inhibit the induction of COX-2 or iNOS proteins. British Journal of Pharmacology (1999) 127, 1589–1596; doi:10.1038/sj.bjp.0702708" @default.
• W2084629567 created "2016-06-24" @default.
• W2084629567 creator A5013333915 @default.
• W2084629567 creator A5032937067 @default.
• W2084629567 creator A5081569271 @default.
• W2084629567 date "1999-08-01" @default.
• W2084629567 modified "2023-10-16" @default.
• W2084629567 title "A771726, the active metabolite of leflunomide, directly inhibits the activity of cyclo-oxygenase-2<i>in vitro</i>and<i>in vivo</i>in a substrate-sensitive manner" @default.
• W2084629567 cites W1496717884 @default.
• W2084629567 cites W1942602161 @default.
• W2084629567 cites W1964979213 @default.
• W2084629567 cites W1974026314 @default.
• W2084629567 cites W1976468624 @default.
• W2084629567 cites W1981690748 @default.
• W2084629567 cites W2008574207 @default.
• W2084629567 cites W2012810767 @default.
• W2084629567 cites W2014916185 @default.
• W2084629567 cites W2019632917 @default.
• W2084629567 cites W2023170094 @default.
• W2084629567 cites W2023603090 @default.
• W2084629567 cites W2042547856 @default.
• W2084629567 cites W2057853327 @default.
• W2084629567 cites W2060152996 @default.
• W2084629567 cites W2078840294 @default.
• W2084629567 cites W2090359132 @default.
• W2084629567 cites W2111540856 @default.
• W2084629567 cites W2113745276 @default.
• W2084629567 cites W2158686638 @default.
• W2084629567 cites W2163155271 @default.
• W2084629567 cites W2171996143 @default.
• W2084629567 doi "https://doi.org/10.1038/sj.bjp.0702708" @default.
• W2084629567 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1566153" @default.
• W2084629567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10455314" @default.
• W2084629567 hasPublicationYear "1999" @default.
• W2084629567 type Work @default.
• W2084629567 sameAs 2084629567 @default.
• W2084629567 citedByCount "78" @default.
• W2084629567 countsByYear W20846295672012 @default.
• W2084629567 countsByYear W20846295672013 @default.
• W2084629567 countsByYear W20846295672014 @default.
• W2084629567 countsByYear W20846295672015 @default.
• W2084629567 countsByYear W20846295672016 @default.
• W2084629567 countsByYear W20846295672017 @default.
• W2084629567 countsByYear W20846295672018 @default.
• W2084629567 countsByYear W20846295672019 @default.
• W2084629567 countsByYear W20846295672020 @default.
• W2084629567 countsByYear W20846295672021 @default.
• W2084629567 countsByYear W20846295672022 @default.
• W2084629567 countsByYear W20846295672023 @default.
• W2084629567 crossrefType "journal-article" @default.
• W2084629567 hasAuthorship W2084629567A5013333915 @default.
• W2084629567 hasAuthorship W2084629567A5032937067 @default.
• W2084629567 hasAuthorship W2084629567A5081569271 @default.
• W2084629567 hasBestOaLocation W20846295672 @default.
• W2084629567 hasConcept C126322002 @default.
• W2084629567 hasConcept C149151106 @default.
• W2084629567 hasConcept C150903083 @default.
• W2084629567 hasConcept C181199279 @default.
• W2084629567 hasConcept C185592680 @default.
• W2084629567 hasConcept C202751555 @default.
• W2084629567 hasConcept C207001950 @default.
• W2084629567 hasConcept C2775905006 @default.
• W2084629567 hasConcept C2777477808 @default.
• W2084629567 hasConcept C2777752497 @default.
• W2084629567 hasConcept C2778078955 @default.
• W2084629567 hasConcept C2779689624 @default.
• W2084629567 hasConcept C2781059491 @default.
• W2084629567 hasConcept C55493867 @default.
• W2084629567 hasConcept C71924100 @default.
• W2084629567 hasConcept C86803240 @default.
• W2084629567 hasConcept C98274493 @default.
• W2084629567 hasConceptScore W2084629567C126322002 @default.
• W2084629567 hasConceptScore W2084629567C149151106 @default.
• W2084629567 hasConceptScore W2084629567C150903083 @default.
• W2084629567 hasConceptScore W2084629567C181199279 @default.
• W2084629567 hasConceptScore W2084629567C185592680 @default.
• W2084629567 hasConceptScore W2084629567C202751555 @default.
• W2084629567 hasConceptScore W2084629567C207001950 @default.
• W2084629567 hasConceptScore W2084629567C2775905006 @default.
• W2084629567 hasConceptScore W2084629567C2777477808 @default.
• W2084629567 hasConceptScore W2084629567C2777752497 @default.
• W2084629567 hasConceptScore W2084629567C2778078955 @default.
• W2084629567 hasConceptScore W2084629567C2779689624 @default.
• W2084629567 hasConceptScore W2084629567C2781059491 @default.
• W2084629567 hasConceptScore W2084629567C55493867 @default.
• W2084629567 hasConceptScore W2084629567C71924100 @default.
• W2084629567 hasConceptScore W2084629567C86803240 @default.
• W2084629567 hasConceptScore W2084629567C98274493 @default.
• W2084629567 hasIssue "7" @default.
• W2084629567 hasLocation W20846295671 @default.
• W2084629567 hasLocation W20846295672 @default.
• W2084629567 hasLocation W20846295673 @default.
• W2084629567 hasOpenAccess W2084629567 @default.
• W2084629567 hasPrimaryLocation W20846295671 @default.
• W2084629567 hasRelatedWork W1999374403 @default.
• W2084629567 hasRelatedWork W2035747340 @default.
• W2084629567 hasRelatedWork W2044587716 @default.
• W2084629567 hasRelatedWork W2075891364 @default.

• next